Defeating Alzheimer's disease and other dementias: a priority for European science and societyBengt Winblad, Henrik Zetterberg, Philippe Amouyel et al.|The Lancet Neurology|2016Cited by 1.7k
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease ContinuumAndréa Lessa Benedet, Natàlia Vilor‐Tejedor, Alyssa Stevensson et al.|JAMA Neurology|2021Cited by 627
Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case reportJoseph F. Arboleda‐Velásquez, Yakeel T. Quiroz, Francisco Lopera et al.|Nature Medicine|2019Cited by 606
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's diseaseOskar Hansson, Charlotte E. Teunissen, Rebecca M. Edelmayer et al.|Alzheimer s & Dementia|2022Cited by 589
A multicentre validation study of the diagnostic value of plasma neurofilament lightNicholas J. Ashton, Oskar Hansson, Shorena Janelidze et al.|Nature Communications|2021Cited by 554